China NT Pharma Group Co Ltd operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China NT Pharma Group Co Ltd with three other
companies in this sector in China:
Tibet Rhodiola Pharmaceutical Holding Company
sales of 796.77 million Chinese Renmimbi [US$125.77 million]
of which 100%
was Pharmaceutical Manufacturing Industry),
GuangYuYuan Chinese Herbal Medicine Co Ltd
(933.68 million Chinese Renmimbi [US$147.38 million]
of which 15%
was Drug Industry), and
Kingworld Medicines Group Limited
(1.05 billion Chinese Renmimbi [US$166.30 million]
of which 90%
was Distribution sales of pharmaceutical and).
During the year ended December of 2016, sales at
China NT Pharma Group Co Ltd were 915.12 million Chinese Renmimbi (US$144.45 million).
increase of 7.9%
versus 2015, when the company's sales were 847.73 million Chinese Renmimbi.
Sales of Proprietary Products Production and Sales saw an increase
that was more than double the company's growth rate: sales were up
40.7% in 2016, from
217.30 million Chinese Renmimbi to 305.64 million Chinese Renmimbi.
Not all segments of China NT Pharma Group Co Ltd experienced an increase in sales in 2016:
sales of Third-Party Pharmaceutical Promotion and S fell 10.6% to 563.66 million Chinese Renmimbi.